CATHY GONZALES: Open Payments
NPI 1861402331 · WEST JORDAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,843 in 98 payments from 21 companies in 2025. Trend: 2023 $709 · 2024 $1,615 · 2025 $1,843
Food & beverage: $1,843
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $324 |
| GENZYME CORPORATION | 24 | $266 |
| Regeneron Healthcare Solutions, Inc. | 11 | $247 |
| GlaxoSmithKline, LLC. | 13 | $212 |
| Grifols USA, LLC | 4 | $86 |
| Lilly USA, LLC | 5 | $78 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $70 |
| Exeltis, USA Inc. | 1 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
Products named: DUPIXENT, NUCALA, AIRSUPRA, TEZSPIRE, Prolastin-C Liquid, MOUNJARO, FASENRA, NEFFY.
Industry payments across UT — which companies pay providers there.
